Chemotherapy may eradicate ductal carcinoma in situ (DCIS) but not the associated microcalcifications
Conclusions DCIS may be completely eradicated by NAC±trastuzumab. However, associated microcalcificatios probably persist. Patients with locally advanced breast cancer with substantial DCIS may still opt for NAC and breast conservation as the DCIS component may respond and even completely disappear following NAC. Residual widespread microcalcificatios after NAC do not necessarily indicate residual cancer. Larger studies are needed to direct the surgical management of these patients.
Source: European Journal of Surgical Oncology (EJSO) - Category: Surgery Source Type: research
More News: Breast Cancer | Breast Carcinoma | Breast Conservation Surgery | Cancer | Cancer & Oncology | Carcinoma | Carcinoma in Situ | Chemotherapy | DCIS (Ductal Carcinoma in Situ) | Ductal Carcinoma | Herceptin | Mammography | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Study | Surgery